Search Results - "Starcevic, Marta"

Refine Results
  1. 1

    Identification of Snapin and Three Novel Proteins (BLOS1, BLOS2, and BLOS3/Reduced Pigmentation) as Subunits of Biogenesis of Lysosome-related Organelles Complex-1 (BLOC-1) by Starcevic, Marta, Dell'Angelica, Esteban C

    Published in The Journal of biological chemistry (02-07-2004)
    “…Biogenesis of lysosome-related organelles complex-1 (BLOC-1) is a ubiquitously expressed multisubunit protein complex required for the normal biogenesis of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Stratification of Antibody-Positive Subjects by Antibody Level Reveals an Impact of Immunogenicity on Pharmacokinetics by Zhou, Lei, Hoofring, Sarah A., Wu, Yu, Vu, Thuy, Ma, Peiming, Swanson, Steven J., Chirmule, Narendra, Starcevic, Marta

    Published in The AAPS journal (01-01-2013)
    “…The availability of highly sensitive immunoassays enables the detection of antidrug antibody (ADA) responses of various concentrations and affinities. The…”
    Get full text
    Journal Article
  6. 6

    Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiency by Cheli, Verónica T., Daniels, Richard W., Godoy, Ruth, Hoyle, Diego J., Kandachar, Vasundhara, Starcevic, Marta, Martinez-Agosto, Julian A., Poole, Stephen, DiAntonio, Aaron, Lloyd, Vett K., Chang, Henry C., Krantz, David E., Dell'Angelica, Esteban C.

    Published in Human molecular genetics (01-03-2010)
    “…Biogenesis of lysosome-related organelles complex 1 (BLOC-1) is a protein complex formed by the products of eight distinct genes. Loss-of-function mutations in…”
    Get full text
    Journal Article
  7. 7

    BLOC-1, a Novel Complex Containing the Pallidin and Muted Proteins Involved in the Biogenesis of Melanosomes and Platelet-dense Granules by Falcón-Pérez, Juan M., Starcevic, Marta, Gautam, Rashi, Dell'Angelica, Esteban C.

    Published in The Journal of biological chemistry (02-08-2002)
    “…Recent studies have led to the identification of a group of genes required for normal biogenesis of lysosome-related organelles such as melanosomes and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein by Nazarian, Ramin, Starcevic, Marta, Spencer, Melissa J, Dell'Angelica, Esteban C

    Published in Biochemical journal (01-05-2006)
    “…Dysbindin was identified as a dystrobrevin-binding protein potentially involved in the pathogenesis of muscular dystrophy. Subsequently, genetic studies have…”
    Get full text
    Journal Article
  10. 10

    Assay signal as an alternative to titer for assessment of magnitude of an antidrug antibody response by Starcevic Manning, Marta, Kroenke, Mark A, Lee, Stephanie A, Harrison, Simon E, Hoofring, Sarah A, Mytych, Daniel T, Jawa, Vibha

    Published in Bioanalysis (01-12-2017)
    “…Titer methods are commonly used to characterize the magnitude of an antidrug antibody response. Assay S/N is an appealing alternative, but the circumstances…”
    Get full text
    Journal Article
  11. 11

    The molecular machinery for the biogenesis of lysosome-related organelles: lessons from Hermansky–Pudlak syndrome by Starcevic, Marta, Nazarian, Ramin, Dell’Angelica, Esteban C

    Published in Seminars in cell & developmental biology (01-08-2002)
    “…Hermansky–Pudlak syndrome (HPS) defines a group of autosomal recessive disorders characterized by defects in lysosome-related organelles such as melanosomes…”
    Get full text
    Journal Article
  12. 12

    Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics by Gorovits, Boris, Wakshull, Eric, Pillutla, Renuka, Xu, Yuanxin, Manning, Marta Starcevic, Goyal, Jaya

    Published in Journal of immunological methods (01-06-2014)
    “…Many biotherapeutics currently in development have complex mechanisms of action and contain more than one domain, each with a specific role or function…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development by Xue, Li, Clements-Egan, Adrienne, Amaravadi, Lakshmi, Birchler, Mary, Gorovits, Boris, Liang, Meina, Myler, Heather, Purushothama, Shobha, Manning, Marta Starcevic, Sung, Crystal

    Published in The AAPS journal (01-11-2017)
    “…Anti-drug antibodies (ADA) pose a potential risk to patient safety and efficacy and are routinely monitored during clinical trials. Pre-existing drug-reactive…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor by Kakkar, Tarundeep, Sung, Cynthia, Gibiansky, Leonid, Vu, Thuy, Narayanan, Adimoolam, Lin, Shao-Lee, Vincent, Michael, Banfield, Christopher, Colbert, Alex, Hoofring, Sarah, Starcevic, Marta, Ma, Peiming

    Published in Pharmaceutical research (01-10-2011)
    “…ABSTRACT Purpose For AMG 317, a fully human monoclonal antibody to interleukin receptor IL-4Rα, we developed a population pharmacokinetic (PK) model by fitting…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Strategic characterization of anti-drug antibody responses for the assessment of clinical relevance and impact by Tatarewicz, Suzanna M, Mytych, Daniel T, Manning, Marta Starcevic, Swanson, Steven J, Moxness, Michael S, Chirmule, Narendra

    Published in Bioanalysis (01-06-2014)
    “…All therapeutic proteins have the potential to induce anti-drug antibodies (ADA). Clinically relevant ADA can impact efficacy and/or safety of a biological…”
    Get full text
    Journal Article
  19. 19

    Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates by Hoofring, Sarah A, Lopez, Rocio, Hock, M Benjamin, Kaliyaperumal, Arunan, Patel, Sonal K, Swanson, Steven J, Chirmule, Narendra, Starcevic, Marta

    Published in Bioanalysis (01-05-2013)
    “…Immunogenicity testing is an important component of clinical development for large-molecule biotherapeutics. New complex types of large molecules, such as…”
    Get full text
    Journal Article
  20. 20

    Quantitative assessment of soluble B7RP-1 in bound and unbound state in normal and Systemic Lupus Erythematosus patients’ plasma (130.4) by Bautista, Ami, Zhou, Lei, Zhang, Ming, Sullivan, Barbara, Belouski, Shelley, Starcevic, Marta, Kaliyaperumal, Arunan, Chirmule, Naren, Jawa, Vibha

    Published in The Journal of immunology (1950) (01-04-2010)
    “…Abstract Membrane associated receptors can undergo shedding following cross-linking with ligand. B7RP-1 receptor is present on B-cells and macrophages and…”
    Get full text
    Journal Article